MG-132

製品コードS2619

MG-132化学構造

分子量(MW):475.62

MG132 is a potent cell-permeable proteasome and calpain inhibitor with IC50s of 0.1 and 1.2 μM for the inhibition of proteasome and calpain, respectively.

サイズ 価格(税別)  
JPY 8300.00
JPY 28220.00
JPY 78020.00

Selleckは効果が一番いいである(S,R,S)-(-)-2のコンフィギュレーションを採用しましたので、MG-132プロテアソームの抑制効果はSigmaの同類製品の効果より著しく高くなります

正常には、p21蛋白はユビキチン化で分解されますが、MG-132はプロテアソームの活性を抑制することを通じて、p21蛋白の貯まりを引き起こします。だから、MG-132の抑制効果は強ければ強いほど、p21蛋白の貯まりは多くなってきます。(検査された蛋白:p21  細胞株:HeLa细胞株 処理条件:濃度5μM 処理時間:6h)

文献中の使用例(47)

カスタマーフィードバック(10)

  • MDA-MB-231 cells were treated with 10 uM MG132 and incubated under normoxia or hypoxia for 4 h. Endogenous interaction between LATS2 and SIAH2 was analysed by immunoprecipitation.

    Nat Cell Biol 2015 17(1), 95-103. MG-132 purchased from Selleck.

    HeLa cells were transfected with control mimic, RMND5A siRNA or miR-138 mimic. After transfection for 36 h, cells were treated with proteasome inhibitor MG132 (20 uM) or Dimethyl sulfoxide (DMSO) for 8 h. Endogenous Exportin-5 protein and RMND5A protein expression was measured by western blotting.

    Nucleic Acids Res 2014 42(1), 458-74. MG-132 purchased from Selleck.

  • HeLa cells were transfected with negative control mimic, miR-138 mimic or RMND5A siRNA. After transfection for 36 h, cells were treated with MG132 (20 uM) or DMSO for 8 h. RMND5A and Exportin-5 protein expression were analyzed by immunocytochemistry. Nuclei were counterstained with DAPI.

    Nucleic Acids Res 2014 42(1), 458-74. MG-132 purchased from Selleck.

     

    TFEB induced autophagy dependent ATZ clearance in vitro. MEF transiently co-transfected with either ATZ plus GFP expressing plasmids or ATZ plus TFEB expressing plasmids were incubated with proteasome inhibitor MG132 or with DMSO for 6 h. Upon MG132 treatment, steady state levels of 52 kDa ATZ band increased in both cells transfected with ATZ plus GFP and with ATZ plus TFEB expressing plasmids. Quantification of band intensities showed a 48% reduction of ATZ in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP, in the absence of the proteasome inhibitor. In MG132 treated cells, a 61% decrease of ATZ was detected in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP.

    EMBO Mol Med 2013 5, 397-412. MG-132 purchased from Selleck.

  • JAK1 expression was analyzed in A375 cells expressing scrambled shRNA or shRNF125 (#2) and treated with MG132 (5 uM, 10 hr), and in Lu1205 cells expressing WT RNF125 and treated with MG132.

    Cell Rep 2015 11(9), 1458-73. MG-132 purchased from Selleck.

    LRB1 and LRB2 regulate phyB protein levels. PhyB protein levels in crude extracts from the wild type (WT) and the indicated mutant backgrounds were assayed by immunoblot analysis with anti-phyB monoclonal antibodies. Anti-PBA1 and anti-histone H3 antibodies were used to confirm equal protein loading. Rc-induced loss of phyB in the wild type is inhibited by 100 uM MG132.

    Plant Physiol 2012 60(1), 118-34. MG-132 purchased from Selleck.

  • Representative images for γ-H2AX-stained cells treated with 100 uM FA for 3 h without or with MG132. Fluorescence was measured in at least 50 nuclei in each of three experiments.

    Toxicol Appl Pharmacol 2015 286(2), 135-41. MG-132 purchased from Selleck.

    GSK-3β phosphorylation at Ser9 is enhanced in NOK-overexpressed stable cell lines. The proteasome inhibitor, MG132, was added in medium of HeLa-HA and HeLa-NOK-HA cells for 12 h and then the p-GSK-3b(Ser9) was assayed by western blotting.

    FEBS Lett 2012 586, 3787–3792. MG-132 purchased from Selleck.

  • Nek2A impedes SuFu ubiquitination. HEK293T cells transfected with Nek2A-Myc and Flag-SuFu for 48 h were treated with MG-132 to enrich ubiquitinated proteins, and subsequently subjected to co-immunoprecipitation assay. Precipitated proteins were probed using anti-Ub antibody.

    Int J Oncol, 2017, 50(2):373-380. MG-132 purchased from Selleck.

    Truncated mouse Period2 (Per2) protein was expressed in NIH3T3 cells, treated by cycloheximide with or without MG132 for 1-4 hours.Per2 was reported to be degraded by the proteasome proteolysis. By adding MG132 (25 μM), a proteasome inhibitor, the degradation of Per2 was dramatically decreased within 4 hours treatment (shown by western blot).

    2012 Dr. Edison DUKE-NUS Graduate Medical School Singapore.. MG-132 purchased from Selleck.

質量管理及び製品安全説明書

Proteasome阻害剤の選択性比較

生物活性

製品説明 MG132 is a potent cell-permeable proteasome and calpain inhibitor with IC50s of 0.1 and 1.2 μM for the inhibition of proteasome and calpain, respectively.
ターゲット
20S proteasome [9]
(Cell-free assay)
100 nM
体外試験

MG-132 displays >1000 times more activity than ZLLal in inhibiting the ZLLL-MCA-degrading activity of 20S proteasome with IC50 of 100 nM versus 110 μM. MG-132 also inhibits calpain with IC50 of 1.2 μM. MG-132 induces neurite outgrowth in PC12 cells at an optimal concentration of 20 nM, displaying 500 times more potency than ZLLal. [1] MG-132 (10 μM) potently inhibits TNF-α-induced NF-κB activation, interleukin-8 (IL-8) gene transcription, and IL-8 protein release in A549 cells by inhibition of proteasome-mediated IκBα degradation. [2] MG-132 treatment potently induces p53-dependent apoptosis in KIM-2 cells by 26S proteasome inhibition. [3] Unlike BzLLLCOCHO or PS-341, MG-132 treatment results in weak inhibition of the chymotrypsinlike (CT-L) and peptidylglutamyl peptide hydrolysing (PGPH) activities of the 26S proteasome, whereas multiple myeloma cells (U266 and OPM-2) are more sensitive to induction of apoptosis by MG-132 than BzLLLCOCHO. [4] MG-132 (1 μM) sensitizes TRAIL-resistant prostate cancer cells by activating the AP-1 family members c-Fos and c-Jun, which, in turn, repress the antiapoptotic molecule c-FLIP(L). [5] MG-132 significantly enhances the ability of inositol hexakisphosphate (IP6) to reduce cellular metabolic activity in both PC3 and DU145 androgen-independent prostate cancer (AIPCa) cell lines. [6]

細胞データ
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
LPS-stimulated RAW264.7 cells NW[5c5VlTnWwY4Tpc44hSXO|YYm= MkTyNlUh|ryP M3m2Z2ROW09? Mo\iTY5pcWKrdIOgcol1emmlIH;4bYRmKHC{b3T1Z5Rqd25id3n0bEBKSzVyIH;mJFAvOSEQvF2= NV;Z[lhCOjR4OUe0PVY>
HL-60 MXfDfZRwfG:6aXOgRZN{[Xl? NFnwVmo1OCEQvF2= NH7INlM1QCCq MXjEUXNQ MVXJR|UxRDFyIN88US=> NFXaS|kzPDZ7N{S5Oi=>
SMMC-7721 NVTReGVMS3m2b4TvfIlkKEG|c3H5 NVnXZolDPDBizszN NYGxc2dUPDhiaB?= MmrWSG1UVw>? MY\JR|UxRTdwMTFOwG0> NFvLbW0zPDZ7N{S5Oi=>
A-549 MoTjR5l1d3SxeHnjJGF{e2G7 Mn3HOFAh|ryP M1rTbVQ5KGh? NXq5THk6TE2VTx?= M1nhZWlEPTB:MUCg{txO NUXjb2wyOjR4OUe0PVY>
MCF-7 NVL3XnU2S3m2b4TvfIlkKEG|c3H5 NWTBVoJEPDBizszN NXPDNItXPDhiaB?= NWi0XlhRTE2VTx?= MVzJR|UxRTdwMzFOwG0> M{fkfFI1Pjl5NEm2
SW-480 M1\IeWN6fG:2b4jpZ{BCe3OjeR?= M3\KfVQxKM7:TR?= MoLVOFghcA>? MVXEUXNQ NI\jWXlKSzVyPUSg{txO MUCyOFY6PzR7Nh?=
NCI-H929 NUTGRXQ5S3m2b4TvfIlkKEG|c3H5 MnOxNUDPxE1? NFvTbGc4OiCq NEKxOlZFVVOR M{GxUWlEPTB;MD6xO{DPxE1? NXW1OodwOjR4MkWwPFg>
293T NF3sdphEgXSxdH;4bYMhSXO|YYm= MYixNEDPxE1? MXm3NkBp Mne4SG1UVw>? NUjHT|h6UUN3MEyyJO69VQ>? MX6yOFYzPTB6OB?=
293T NVWwWWFLTnWwY4Tpc44hSXO|YYm= NGTufZIyOCEQvF2= NE\VXoIzPCCq MX7EUXNQ NE\OZpJOd2SncnH0[Yx6KGmwZIXj[ZMhcGWjdD3zbI9kcyBi NIOyWlIzPDZ{NUC4PC=>
HeLa NYLJOVVsU2mwYYPlJGF{e2G7 M4TlWFExKM7:TR?= M4DpOVEhcA>? NE\HSIRFVVOR MlnFTY5lfWOnczDQRXJRKGOuZXH2ZYdmKGK7IHnubIljcXSrbnegdJJwe2Wjc3;t[UBi[3Srdnn0fS=> MnewNlQ{OjF6M{O=
MDA-MB-231 NYrBc2hmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEDvbW8yKM7:TR?= MWi3NkBp M{[xVmROW09? NX7DR403UUN3ME2wMlE5KM7:TR?= NYrvVVJnOjRzNUOyNFY>
MCF-7 M1HHcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4rlSVEh|ryP NXPBZohVPzJiaB?= M33udGROW09? MlLkTWM2OD1yLkGzJO69VQ>? MoPPNlQyPTN{ME[=
MCF10A MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{Xh[|Eh|ryP NYO3OnNUPzJiaB?= NXrYW2ZxTE2VTx?= NWSyPG5CUUN3ME2wMlI6KM7:TR?= MmjZNlQyPTN{ME[=
HEK-293 MonTT4lv[XOnIFHzd4F6 MoPUNkBidmRiMkCg{txO NEX4XZYzKGh? M4fGWWROW09? MnzzTY5pcWKrdIOgR4hVNUxiYXP0bZZqfHlid3n0bEBKSzVyIH;mJFkhdk1i NWTUb41NOjN3NEC3PVA>
Calu6 Mn75SpVv[3Srb36gRZN{[Xl? NHzscXIyOCEQvF2= NX30emhsOThiaB?= NH;TcWFFVVOR Moq3V4lodmmoaXPhcpRtgSCjY3P1cZVt[XSnczDmdoF1[XirbjDwdoVkfXK|b4K= MonqNlM2ODZ2OE[=
IFN-gamma-induced RAW264.7 NWXZb3pKTnWwY4Tpc44hSXO|YYm= NIHoU|FFVVOR NF3MZpJKdmirYnn0d{BvcXS{aXOgc5hq\GVicILv[JVkfGmxbjD3bZRpKEmFNUCgc4YhOC5yN{eg{txO M2frPVIzOjd5Mke3
IPC227F M2fBcWN6fG:2b4jpZ{BCe3OjeR?= NUDtWZRSOSEQvF2= NWLob2xsPDhiaB?= NXjuSZZbTE2VTx?= NIXiN41KSzVyPUCuNFc4KM7:TR?= M1vCelIyQTJ2NUK4
Hepa-1c1c7 M1X1bmZ2dmO2aX;uJGF{e2G7 NVLhSnp{OjVizszN NWC4[G44PiCq M1PUVWROW09? NVL6[oUyUW6lcnXhd4V{KE6{ZkKgdJJwfGWrbjDs[ZZmdA>? NX3zSnlyOjB|OUK1OFQ>
COS-7 M3rtemN6fG:2b4jpZ{BCe3OjeR?= NYXUOoNXOTBizszN NUficJFvTE2VTx?= M{jvTGlEPTB:MUCg{txO MoLwNVgxQDhyOUe=
HuH-7 NWH5WlAzS3m2b4TvfIlkKEG|c3H5 MXGxNEDPxE1? NXrPW41lTE2VTx?= M4r3TmlEPTB:MUCg{txO MkDWNVgxQDhyOUe=
OCI-Ly3 MYDGeY5kfGmxbjDBd5NigQ>? NEmyOGQyOCEQvF5CpC=> MnvhOEBp MniwSG1UVw>? NWXzXnRYUW6mdXPld{BpfW2jbjDJb4FxeGGEYXzwbIEhe3SjYnnsbZpifGmxbjD3bZRpKEWFNUCgc4YhOSEQvF2= NGLXTlUyQDB{NEGxNy=>
A2780 cDDP NUPIcJlqSXCxcITvd4l{KEG|c3H5 NEnsTYUzPCCq M4\LRmROW09? M4\6RWlv\HWlZYOgZZBweHSxc3nzJIJ6KGmwaHnibZRqdmdiUGTFUkBl\We{YXTheIlwdg>? MkDhNVc3QDRyMUi=
LPS-stimulated RAW264.7 cells MoHVSpVv[3Srb36gRZN{[Xl? MWDEUXNQ NV;jOm94UW6qaXLpeJMhVkZva3HwdIFDKESQQTDibY5lcW6p MmfsNVc1ODd{N{e=
PC12 M2j1eWZ2dmO2aX;uJGF{e2G7 M3vkV|ExOCEQvF5CpC=> NXrBSoFkOjRiaB?= NFq4dJdFVVOR MXTJcohq[mm2czC2MW9JTEFvIHHu[EBJOk9{LXnu[JVk\WRiY4n0c5RwgGmlaYT5 M2myVlE4OTV6NEW0
PC3 NYjJW4pPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXSyNEDPxE1? M2C0PFQ5KGh? NIGySIpFVVOR NXXPPWxLUUN3ME2wMlYh|ryP MUGxOlY5PjV|Nx?=
LP-1 M2HFdGFxd3C2b4Ppd{BCe3OjeR?= NHnJU4U{ODBibl2= NEXkV2wzPCCq NVjodGV1TE2VTx?= MXjJcoR2[2W|IHHwc5B1d3OrczDifUBqdmO{ZXHzbY5oKGOuZXH2[YQhWEGUUDDs[ZZmdCCjbnSgdoVlfWOrbnegUYNtNTFicILveIVqdiCuZY\lcC=> NWLnXFdWOTV7NUi1PFk>
ES6 NYX3Noh3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUPJR|UxRTBwMEGzNFYh|ryP NX3icGJTW0GQR1XS
A101D NWHJfoV6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVLvS|FTUUN3ME2wMlA{Ojd7IN88US=> Mm\PV2FPT0WU
OCUB-M M{PkSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUn3SIZkUUN3ME2wMlA{PzN5IN88US=> NYXh[Zc1W0GQR1XS
LB2518-MEL MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4jNOGlEPTB;MD6wN|c3KM7:TR?= NEDZUpZUSU6JRWK=
SH-4 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVXJR|UxRTBwMESzNUDPxE1? M4q2fnNCVkeHUh?=
KNS-42 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWXMPYpGUUN3ME2wMlA1PDRzIN88US=> M2fGOnNCVkeHUh?=
DSH1 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnLtTWM2OD1yLkC1Nlg6KM7:TR?= MXXTRW5ITVJ?
NTERA-S-cl-D1 M1PoOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUfJR|UxRTBwMEW3O|Ih|ryP M4jlXHNCVkeHUh?=
D-542MG NHTjepJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWjJR|UxRTBwMEW5OVch|ryP NVvR[lBiW0GQR1XS
KS-1 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkXLTWM2OD1yLkC2OFU5KM7:TR?= Ml3qV2FPT0WU
BL-41 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHzQfJlKSzVyPUCuNFY6PDdizszN MnzHV2FPT0WU
LXF-289 NXrk[YdFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYfFZmVuUUN3ME2wMlA4ODZ4IN88US=> M1H4bHNCVkeHUh?=
D-247MG NFftfWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1XCUmlEPTB;MD6wO|IxQSEQvF2= NHTFS|dUSU6JRWK=
MMAC-SF M2jScmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml7kTWM2OD1yLkC3NlY5KM7:TR?= NEnUcmhUSU6JRWK=
CP66-MEL NXHjZXNPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIDvZ4NKSzVyPUCuNFc2KM7:TR?= MXjTRW5ITVJ?
LB771-HNC Mom0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlnNTWM2OD1yLkC4NFM3KM7:TR?= M2j4T3NCVkeHUh?=
no-10 Mn[3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXrGZWZvUUN3ME2wMlA5QTB7IN88US=> MmHSV2FPT0WU
A388 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUDJR|UxRTBwMEmwOlUh|ryP NG\6e3ZUSU6JRWK=
OPM-2 M37mdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{m5[WlEPTB;MD6xNFQ4PCEQvF2= Mlr2V2FPT0WU
OVCAR-4 Mk\XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\JR|UxRTBwMUC5N|gh|ryP NITSWJBUSU6JRWK=
HOP-62 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\3VFJKSzVyPUCuNVA6PDlizszN NG[3N5JUSU6JRWK=
ML-2 NGO5TI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVv6eXRPUUN3ME2wMlEyQDB4IN88US=> MojkV2FPT0WU
UACC-257 NIOwSHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTBwMUG5Nlch|ryP M{\kPHNCVkeHUh?=
NEC8 NVThZnd7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXTJR|UxRTBwMUG5PVUh|ryP MkizV2FPT0WU
ONS-76 M13TVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmqwTWM2OD1yLkGyPVM2KM7:TR?= NGnWW4pUSU6JRWK=
KE-37 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmS3TWM2OD1yLkGzNlc5KM7:TR?= NFy0[Y1USU6JRWK=
HT-144 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn\BTWM2OD1yLkGzPFk2KM7:TR?= MXXTRW5ITVJ?
LB2241-RCC MmTuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoKwTWM2OD1yLkG0NlQ4KM7:TR?= NVXaPGFuW0GQR1XS
TE-5 NWjKSplwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHX0R|hKSzVyPUCuNVQzPzhizszN Mn7iV2FPT0WU
KINGS-1 M1\PVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFS3[JlKSzVyPUCuNVQ4QSEQvF2= MkLkV2FPT0WU
NCI-H69 NWnY[FlZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV\mVVQ1UUN3ME2wMlE2OTRzIN88US=> NXv2NXdoW0GQR1XS
CAS-1 NV7tRYlYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYTxOZdtUUN3ME2wMlE2PDh{IN88US=> NGCyNYJUSU6JRWK=
D-263MG MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn;vTWM2OD1yLkG2NFA3KM7:TR?= NFW0[2hUSU6JRWK=
A253 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M13FUmlEPTB;MD6xOlEzQCEQvF2= NHzQZVdUSU6JRWK=
PF-382 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYWwco9uUUN3ME2wMlE3PzB4IN88US=> MoTFV2FPT0WU
CESS NHHPUo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH33TYdKSzVyPUCuNVcxPiEQvF2= M3i1SnNCVkeHUh?=
MZ2-MEL MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mo\xTWM2OD1yLkG3OVU6KM7:TR?= MYXTRW5ITVJ?
HEL MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4nHdWlEPTB;MD6xPFUyPyEQvF2= MlXKV2FPT0WU
D-392MG M1PzW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGPSZmVKSzVyPUCuNVkyOTVizszN MmXsV2FPT0WU
SK-LMS-1 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWrJR|UxRTBwMUmzNFMh|ryP MUnTRW5ITVJ?
GI-ME-N M1e1PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWrSNmRTUUN3ME2wMlE6OzB4IN88US=> NH;yW5ZUSU6JRWK=
LB831-BLC NFHrVpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NInDWnBKSzVyPUCuNVk{PCEQvF2= NH;PcGlUSU6JRWK=
DU-4475 M1PsUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYjJR|UxRTBwMUm2OVgh|ryP NHfIcFBUSU6JRWK=
IST-SL1 NFX6PHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4jjbmlEPTB;MD6yNFA6PCEQvF2= M2q4dnNCVkeHUh?=
GAK M2fhXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVjWRXJqUUN3ME2wMlIxPTN2IN88US=> M3fK[nNCVkeHUh?=
EW-1 Mn\tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVfJR|UxRTBwMkGwOFch|ryP NYTq[IRHW0GQR1XS
LAMA-84 NH33UJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFGyUZJKSzVyPUCuNlE5PTFizszN MnnwV2FPT0WU
SK-UT-1 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVP0[HM1UUN3ME2wMlIzODR7IN88US=> M3XWS3NCVkeHUh?=
VA-ES-BJ MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml\lTWM2OD1yLkKyNlU4KM7:TR?= Mo\LV2FPT0WU
ACN Mly4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHPtZoxKSzVyPUCuNlI3OzhizszN NF71N5JUSU6JRWK=
SK-PN-DW Mn\IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{fFN2lEPTB;MD6yN|E6KM7:TR?= NEfGNmdUSU6JRWK=
HD-MY-Z MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEnRfYVKSzVyPUCuNlM{ODNizszN NFTKOJhUSU6JRWK=
LB373-MEL-D M{nlZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml;mTWM2OD1yLkK0NVk5KM7:TR?= M4Lu[3NCVkeHUh?=
COLO-829 MmXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH\u[lNKSzVyPUCuNlQzPTdizszN MlTZV2FPT0WU
ES8 NF7X[VlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{DnfmlEPTB;MD6yOFc3OyEQvF2= MV;TRW5ITVJ?
RXF393 MnjvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MknTTWM2OD1yLkK1NFE2KM7:TR?= MonVV2FPT0WU
TK10 NGfKOndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGLSNmpKSzVyPUCuNlU1OzVizszN NW\MNXZVW0GQR1XS
LOUCY MkfBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV;6THYzUUN3ME2wMlI2PDV4IN88US=> MYrTRW5ITVJ?
MZ7-mel MlnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV;JR|UxRTBwMk[zO|Qh|ryP NXvuOXhtW0GQR1XS
CP67-MEL MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkXFTWM2OD1yLkK2O|Mh|ryP M3PsU3NCVkeHUh?=
C2BBe1 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmPKTWM2OD1yLkK3PVA4KM7:TR?= MVjTRW5ITVJ?
K052 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEi1WVdKSzVyPUCuNlg6QSEQvF2= NEnlbWxUSU6JRWK=
MOLT-16 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVnNcpV2UUN3ME2wMlI6PTJ2IN88US=> Mki1V2FPT0WU
KNS-81-FD NXvyVJI5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIXD[5RKSzVyPUCuN|A{OjNizszN MnuyV2FPT0WU
CMK MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1:0bGlEPTB;MD6zNVEzKM7:TR?= NV;q[IF{W0GQR1XS
LAN-6 M4DqT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2DEVWlEPTB;MD6zNVMh|ryP MnThV2FPT0WU
KLE NEfPdpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWDGN3BRUUN3ME2wMlMyOzB4IN88US=> NUX0VWNqW0GQR1XS
NCCIT NGSzfXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHPKdWdKSzVyPUCuN|E4QDNizszN NH3lcnFUSU6JRWK=
HH MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MW\JR|UxRTBwM{K4PVch|ryP NFfTNodUSU6JRWK=
TE-8 MkHHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYn4PIQ1UUN3ME2wMlM1Ojd7IN88US=> M3;xbXNCVkeHUh?=
GDM-1 MkjhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mkn6TWM2OD1yLkO1NVA1KM7:TR?= MWnTRW5ITVJ?
NCI-H747 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTBwM{exNFMh|ryP M{C4WHNCVkeHUh?=
NCI-H1092 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXTJR|UxRTBwM{i4OFQh|ryP M3;0XXNCVkeHUh?=
8-MG-BA MmrYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXTJR|UxRTBwM{m4N|ch|ryP M3PRcHNCVkeHUh?=
NB17 Mkf0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{jGRWlEPTB;MD60Nlk4KM7:TR?= MVPTRW5ITVJ?
LC4-1 M17mZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV;MWFkxUUN3ME2wMlQ{PjB5IN88US=> NFLSRmdUSU6JRWK=
TE-1 NX32SFV7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn7pTWM2OD1yLkS1NVE6KM7:TR?= NHfXU4hUSU6JRWK=
KALS-1 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIfMO2dKSzVyPUCuOFY2QDRizszN MkLqV2FPT0WU
CCRF-CEM NIq2eVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXTje5hvUUN3ME2wMlQ4Pjd2IN88US=> NXTPeJNqW0GQR1XS
OS-RC-2 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmnsTWM2OD1yLkS3PVczKM7:TR?= MomzV2FPT0WU
A704 MnrWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2DwUmlEPTB;MD60PFY6OiEQvF2= MnPuV2FPT0WU
BB49-HNC M2\obWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1TGeWlEPTB;MD60PVA6PiEQvF2= NH3se2tUSU6JRWK=
EVSA-T MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXzJR|UxRTBwNEm5NVEh|ryP NFLBXZJUSU6JRWK=
Mo-T MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXvJR|UxRTBwNUG3OlIh|ryP MW\TRW5ITVJ?
MONO-MAC-6 NYDT[XlZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2PEXmlEPTB;MD61N|YyOSEQvF2= NU[4NoNXW0GQR1XS
BB65-RCC MofwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEPSSphKSzVyPUCuOVY5OTFizszN NX\UT2lQW0GQR1XS
NCI-H1882 M4Xlc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn3NTWM2OD1yLkW5NFM3KM7:TR?= M2OwWnNCVkeHUh?=
TE-9 NF3wfpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYPvXWVWUUN3ME2wMlYyODN|IN88US=> NFOxdItUSU6JRWK=
NCI-H2126 M1;kb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYDxSW9vUUN3ME2wMlYzPjZ7IN88US=> M1nmeHNCVkeHUh?=
SF268 MmPJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlvJTWM2OD1yLk[1OlQyKM7:TR?= NEDjfoZUSU6JRWK=
SW872 M2nicGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF[2TmRKSzVyPUCuOlU4OjlizszN MUjTRW5ITVJ?
LS-513 NVmwbnZ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEW1d5NKSzVyPUCuOlY4PTFizszN MXfTRW5ITVJ?
NCI-H1355 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUDBRoFzUUN3ME2wMlY5PjF7IN88US=> NUnI[2JUW0GQR1XS
BL-70 NWLvW4NGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTBwNkmzPFgh|ryP MWfTRW5ITVJ?
NCI-SNU-5 NUP2emJiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWPJR|UxRTBwNkm1OFUh|ryP MXrTRW5ITVJ?
SNU-C2B NFPWephIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFjycZFKSzVyPUCuO|A4OzlizszN NXz5[XliW0GQR1XS
GB-1 NFL6S|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXe4NlBwUUN3ME2wMlczOTJ2IN88US=> M3XYcnNCVkeHUh?=
CTB-1 NIjtSWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTBwN{e5OVUh|ryP NGnMTHNUSU6JRWK=
Becker Mn\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUTJR|UxRTBwN{m2NlEh|ryP M2DUdnNCVkeHUh?=
KM12 NWHvbFB2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{nqXmlEPTB;MD64OVQ3PiEQvF2= NUD3OYNnW0GQR1XS
ES7 M1TxVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3T2ZmlEPTB;MD64PVY2KM7:TR?= MWjTRW5ITVJ?
COLO-684 NEDWTYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn2zTWM2OD1yLkmwOlU5KM7:TR?= MmHYV2FPT0WU
HCC2998 MlvMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkTHTWM2OD1yLkmzPFU1KM7:TR?= MmDFV2FPT0WU
TE-10 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4[3VmlEPTB;MD65OlQ{KM7:TR?= M3fDfXNCVkeHUh?=
SF126 NFe0fJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIjDUG1KSzVyPUCuPVg6PzFizszN MUjTRW5ITVJ?
EKVX NF3QbVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnXkTWM2OD1zLkCzOFQzKM7:TR?= NIPRPWdUSU6JRWK=
KARPAS-45 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX;Lb5dWUUN3ME2xMlA1ODF4IN88US=> M1nncnNCVkeHUh?=
KGN MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2jWb2lEPTB;MT6wOVA1PSEQvF2= MkTLV2FPT0WU
ES1 NXHZPZhLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3XPWWlEPTB;MT6wO|kzOSEQvF2= MXLTRW5ITVJ?
L-540 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4jXRWlEPTB;MT6xNVg{QSEQvF2= M37HXHNCVkeHUh?=
KURAMOCHI M1vyeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWTJR|UxRTFwMUKzO|Qh|ryP NVHHdWJIW0GQR1XS
LU-65 NWHQUYFmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFTm[2ZKSzVyPUGuNVI4PTNizszN MorzV2FPT0WU
MFH-ino NHKwSWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYnWS|FbUUN3ME2xMlE4PTBzIN88US=> MVLTRW5ITVJ?
NCI-H23 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGDpemxKSzVyPUGuNlA1OSEQvF2= NFL1TGlUSU6JRWK=
IA-LM MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUfJR|UxRTFwMkSxNVYh|ryP NUDwUJBtW0GQR1XS
PSN1 NFzBcnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2frWWlEPTB;MT6yO|AyPiEQvF2= M{HIVHNCVkeHUh?=
NCI-H719 NETVXXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mo\DTWM2OD1zLkK3OFEyKM7:TR?= NVrqS5VTW0GQR1XS
SW684 NHXPT4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEPNV4pKSzVyPUGuNlg3PTlizszN Mn7LV2FPT0WU
HCE-4 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXzTUG45UUN3ME2xMlMxOjJzIN88US=> NF;GdXNUSU6JRWK=
EW-16 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmLTTWM2OD1zLkOxN|Q4KM7:TR?= MXvTRW5ITVJ?
NCI-H128 NXLBVGszT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHnLPZlKSzVyPUGuN|U5OTRizszN NV71NmdCW0GQR1XS
HC-1 NE\BOVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3XtNmlEPTB;MT6zPFE4KM7:TR?= NUf2N4E{W0GQR1XS
IST-MES1 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4[1U2lEPTB;MT60NFIxQCEQvF2= Mln5V2FPT0WU
Raji M1vYUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1HKSmlEPTB;MT60NVg2KM7:TR?= Mn\zV2FPT0WU
DMS-114 MmjyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLiZXpuUUN3ME2xMlQ1PTN7IN88US=> NGPTZpFUSU6JRWK=
GI-1 NV74V201T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV3JR|UxRTFwNEexN|Eh|ryP M{DtZnNCVkeHUh?=
NCI-H2081 NGLnZWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGXMfI5KSzVyPUGuOVUyQTZizszN M3q3T3NCVkeHUh?=
LC-1F NX72XlZZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4nkZ2lEPTB;MT61OVE6QCEQvF2= NFHQbHZUSU6JRWK=
NCI-H2227 NH;zeVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYf6cYExUUN3ME2xMlYyPTZzIN88US=> MXzTRW5ITVJ?
D-502MG NGrzO|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWjJR|UxRTFwNkeyNVEh|ryP MXzTRW5ITVJ?
NCI-H2141 M1LYVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NULISnhvUUN3ME2xMlY4OzF5IN88US=> M37CU3NCVkeHUh?=
LS-411N MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYrJR|UxRTFwNkm4NFch|ryP M{Hhd3NCVkeHUh?=
SU-DHL-1 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVPRNW9HUUN3ME2xMlcyOjhzIN88US=> Mn3zV2FPT0WU
BB30-HNC Mnj1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnHlTWM2OD1zLkeyOlg2KM7:TR?= M1nrZ3NCVkeHUh?=
TE-15 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1jBVWlEPTB;MT65NlM4OyEQvF2= MlzuV2FPT0WU
JVM-3 M4nGRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnfPTWM2OD1zLkmzPVA1KM7:TR?= NGjpUpFUSU6JRWK=
IST-SL2 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWjJR|UxRTJwMEGyOVIh|ryP NVnxOYFEW0GQR1XS
EW-18 MkPrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFvmVYZKSzVyPUKuNFI{OzdizszN Mn\lV2FPT0WU
DJM-1 NHHMbINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1fje2lEPTB;Mj6wNlU2OiEQvF2= MXzTRW5ITVJ?
no-11 M2TBb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnnTTWM2OD1{LkCzNVA1KM7:TR?= M4nh[3NCVkeHUh?=
QIMR-WIL NWDTXWlsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGLaPXdKSzVyPUKuNVY4PjJizszN NGnwNHVUSU6JRWK=
MC-CAR NWLm[ld[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF7mbW1KSzVyPUKuNlI6PSEQvF2= MmmyV2FPT0WU
KM-H2 NITxPJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGfvfGlKSzVyPUKuNlkxPDNizszN M1;Qe3NCVkeHUh?=
ECC12 NWXsTXd6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3PMdGlEPTB;Mj6zO|k1KM7:TR?= M1;4PXNCVkeHUh?=
HCE-T MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fEcmlEPTB;Mj60OFg5OyEQvF2= NHOxeXVUSU6JRWK=
MFM-223 NHTtW2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkTZTWM2OD1{LkWwPFcyKM7:TR?= MVTTRW5ITVJ?
SW982 NEnQbnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEH1e3dKSzVyPUKuOVE1QCEQvF2= MUjTRW5ITVJ?
KG-1 NV7jTmhPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIjzUJpKSzVyPUKuPFg4QTFizszN Mn[yV2FPT0WU
ES4 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF;kZYVKSzVyPUOuNFYyOTFizszN NGfMTmNUSU6JRWK=
SCC-3 NYThWFk3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGP2bIFKSzVyPUOuNVA5PDhizszN NWjsUo16W0GQR1XS
RH-1 MlnZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3zN[2lEPTB;Mz6zPFc1QCEQvF2= MkO5V2FPT0WU
NCI-H748 MlrCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NULpOG5EUUN3ME2zMlQ1OjZ4IN88US=> NUnkbFRVW0GQR1XS
HCC2218 M{DLbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWXHbYNbUUN3ME2zMlQ3QTN5IN88US=> MY\TRW5ITVJ?
MEG-01 NUTnbI0yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXXCNXI6UUN3ME2zMlU6PjhizszN NGXHc5pUSU6JRWK=
NB12 MlLlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVPJR|UxRTNwNUm4PFgh|ryP MXvTRW5ITVJ?
SNB75 M1vINmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFrySIRKSzVyPUOuOlAyODNizszN NVPBcYFVW0GQR1XS
KMS-12-PE MmrIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUXJR|UxRTNwNke3NlMh|ryP MnvXV2FPT0WU
SKM-1 NUTNdZRnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NE\ZfnhKSzVyPUOuO|E{PzZizszN NX;VTIJ7W0GQR1XS
COLO-320-HSR Mmn4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnHRTWM2OD1|Lke1OlM1KM7:TR?= NH6xbYVUSU6JRWK=
NKM-1 NVr4T5JST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVXJR|UxRTNwN{ezO|gh|ryP M1\JenNCVkeHUh?=
TE-6 NH;jV|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTNwOUS1OlEh|ryP NH\EXIJUSU6JRWK=
D-336MG MoC4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXTJR|UxRTRwMEGxOlYh|ryP MlKyV2FPT0WU
NCI-H1650 M3XsSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUjJR|UxRTRwMUW3PVch|ryP MkfYV2FPT0WU
ES3 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MojlTWM2OD12LkOyPFI1KM7:TR?= MUXTRW5ITVJ?
YT NU\qbXhUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{H4V2lEPTB;ND6zOVQzPCEQvF2= NV64OmtLW0GQR1XS
ES5 NIj1bW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmjaTWM2OD12LkSwNlU2KM7:TR?= NXjvd2JuW0GQR1XS
LB647-SCLC NITH[nRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYfJR|UxRTRwNU[zNFgh|ryP NHnFR45USU6JRWK=
HAL-01 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUDJR|UxRTRwNUewN|Qh|ryP NHe0ZpNUSU6JRWK=
LP-1 NHXxfo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX\0cIM4UUN3ME20MlczOzdzIN88US=> MYnTRW5ITVJ?
BC-1 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYPafnRXUUN3ME21MlAxPDR5IN88US=> MmS1V2FPT0WU
EB-3 NGPkPHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYjJR|UxRTVwMEOwOFEh|ryP NHq5d3RUSU6JRWK=
GT3TKB NFq3V29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3i5bmlEPTB;NT6xO|Y3OiEQvF2= NUDYfoFwW0GQR1XS
NCI-H209 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXzEW5RUUUN3ME21MlE6OzV{IN88US=> NHvt[ItUSU6JRWK=
BT-474 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWrwZZFTUUN3ME21MlI{OTB{IN88US=> MoPrV2FPT0WU
RKO MoS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIroN2tKSzVyPUWuNlM1OjJizszN NYGxeXhzW0GQR1XS
SIMA MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGD5ZlBKSzVyPUWuN|A4PjVizszN NF3uTpRUSU6JRWK=
RL MmLHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoHCTWM2OD13LkO3OVQyKM7:TR?= NXjDZoZ6W0GQR1XS
GCIY MkTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXzxfotNUUN3ME21MlQ4OjN4IN88US=> MkS5V2FPT0WU
Calu-6 NIXBXlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M322emlEPTB;NT62NlIh|ryP NFjacZdUSU6JRWK=
ALL-PO MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUD5fmN{UUN3ME21MlY{Pzl3IN88US=> Mnf6V2FPT0WU
ARH-77 M3O3bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4jKd2lEPTB;NT62O|A5PyEQvF2= MUfTRW5ITVJ?
A4-Fuk MnXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3TKXWlEPTB;Nj6wPFEyQCEQvF2= MmnpV2FPT0WU
NCI-H1581 NUTnVGtET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWTJR|UxRTZwMkO4OFkh|ryP NWfwclV6W0GQR1XS
HUTU-80 NXHKZXFoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFjNeVNKSzVyPU[uN|Y5QTdizszN M{CzS3NCVkeHUh?=
TGW NF7BU3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn3DTWM2OD14LkS1OVk{KM7:TR?= M{jKbnNCVkeHUh?=
SK-N-FI NXvzU2htT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkHhTWM2OD14LkS1PFU1KM7:TR?= M{TjUHNCVkeHUh?=
U-266 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3TpSWlEPTB;Nj61NVkzPiEQvF2= MVnTRW5ITVJ?
EM-2 NIj3WWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXTqeIZIUUN3ME22MlY4ODl7IN88US=> MoPtV2FPT0WU
NMC-G1 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3\hTGlEPTB;Nj63NVg6PSEQvF2= NXHTNnE4W0GQR1XS
KASUMI-1 M2m5emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEGwbItKSzVyPU[uPFQ4QDdizszN MlraV2FPT0WU
NALM-6 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUfJR|UxRTZwOE[3OVQh|ryP Mmi4V2FPT0WU
OCI-AML2 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHrGemtKSzVyPUeuNFA{OjZizszN NV7ITYRXW0GQR1XS
SHP-77 MnKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX;JR|UxRTdwMkK0N{DPxE1? M{DXWXNCVkeHUh?=
NOMO-1 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX\ueIFUUUN3ME23MlI1OjV2IN88US=> NXWzfmFmW0GQR1XS
SK-N-DZ MkLrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGP1fJpKSzVyPUeuO|ExQDlizszN NIXxU3RUSU6JRWK=
LB1047-RCC NX34TXZMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3S5dWlEPTB;Nz63NlI{OSEQvF2= MknVV2FPT0WU
MZ1-PC M1;xO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2LXbGlEPTB;Nz64OlU2QCEQvF2= NXvacpVSW0GQR1XS
NB10 MnXtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3ji[WlEPTB;Nz65PVU2PiEQvF2= MmH0V2FPT0WU
RL95-2 M13Le2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEDj[WFKSzVyPUiuNVA5PDJizszN NWDPZ4Q5W0GQR1XS
OMC-1 NW\tV3dWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVjJR|UxRThwNUKxPVEh|ryP MlTvV2FPT0WU
D-283MED MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3PUNmlEPTB;OD65NVcyQSEQvF2= MVPTRW5ITVJ?
MC116 NWLXd2NVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1\WVGlEPTB;OD65O|k1KM7:TR?= MnXuV2FPT0WU
SJSA-1 NWraW5J2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYTJR|UxRTlwMEmwPVEh|ryP MXPTRW5ITVJ?
JiyoyeP-2003 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHjGRmdKSzVyPUmuNlk{OTdizszN NF\hT|FUSU6JRWK=
IST-MEL1 M1Pr[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1HKPWlEPTB;OT63OFE6QCEQvF2= MYrTRW5ITVJ?
CTV-1 MlP3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYnFZnZWUUN3ME2xNE4xQTd7IN88US=> NYLYNVB6W0GQR1XS
NH-12 MlO2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXQTWM2OD1zMD6yOFM{KM7:TR?= NUX3RYt{W0GQR1XS
CA46 Ml;uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYfJR|UxRTFyLkO2NUDPxE1? M1fJdXNCVkeHUh?=
NCI-SNU-1 MoC0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVTQcHJtUUN3ME2xNE41QTZ7IN88US=> MnKzV2FPT0WU
SCLC-21H MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn7aTWM2OD1zMD62OVk3KM7:TR?= M3j0eHNCVkeHUh?=
EC-GI-10 Ml;WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX;JR|UxRTFyLkewN|Eh|ryP M2nZdXNCVkeHUh?=
SR M1r4eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1KycWlEPTB;MUGuNFE5PSEQvF2= NXn4NlBGW0GQR1XS
NCI-H1648 NH;SVI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn:xTWM2OD1zMT6wPVY2KM7:TR?= NGXXPG5USU6JRWK=
TGBC1TKB M2TZb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF3TN2ZKSzVyPUGxMlQyODJizszN M3jkdHNCVkeHUh?=
EW-11 NGi5PFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2HHdmlEPTB;MUGuOVE5PiEQvF2= NWHYdm9MW0GQR1XS
SK-MM-2 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MknaTWM2OD1zMT64NFYyKM7:TR?= NInWWGhUSU6JRWK=
NCI-H524 M2PCNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIeyZVJKSzVyPUGxMlk5OjJizszN NWr0VXAyW0GQR1XS
NOS-1 NFfyW2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWnJR|UxRTF{LkCzOFUh|ryP NYjSeHp4W0GQR1XS
AM-38 MofaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVzJR|UxRTF{LkW2N|Mh|ryP NH61VZFUSU6JRWK=
A498 M37kSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlvzTWM2OD1zMj63NFY6KM7:TR?= MlLuV2FPT0WU
KARPAS-422 NYXySWYxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF7PUWJKSzVyPUGyMlc1QTZizszN NHP6VVFUSU6JRWK=
LU-139 NUDBeVFkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1The2lEPTB;MUKuPVAzPiEQvF2= NVXISFZtW0GQR1XS
COR-L88 NX;qU3pYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHixOmRKSzVyPUGyMlk{QDJizszN MX\TRW5ITVJ?
K5 MojLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4\SVGlEPTB;MUKuPVQ3OiEQvF2= NYHUV5pzW0GQR1XS
NB13 NV3We2RJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV7JR|UxRTF{Lkm3PFMh|ryP NYH6W4FwW0GQR1XS
MRK-nu-1 NUjidYR7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWHEdHpWUUN3ME2xN{4yQTVizszN NGrIboJUSU6JRWK=
MHH-NB-11 NI\4NG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVnq[JlvUUN3ME2xN{4zQTB{IN88US=> NHvrTotUSU6JRWK=
KU812 MoDDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2[2SWlEPTB;MUOuOlEzPCEQvF2= MoDkV2FPT0WU
TE-12 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4LyfWlEPTB;MUOuOlk6PCEQvF2= NYL2Um1wW0GQR1XS
NCI-N87 NHLqOW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4exfWlEPTB;MUOuO|M3KM7:TR?= NXy1PVlQW0GQR1XS
EB2 Ml7WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUSxS3l[UUN3ME2xN{45PTB3IN88US=> M4\zPXNCVkeHUh?=
DB MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWLJR|UxRTF|Lkm4PFUh|ryP NES5[VhUSU6JRWK=
697 NWTJbVZyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NW[5NW9ZUUN3ME2xOE41PTFzIN88US=> MW\TRW5ITVJ?
MSTO-211H M1\td2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{nufmlEPTB;MUSuO|Q1QCEQvF2= NFjie3NUSU6JRWK=
JVM-2 NIfsNVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1HJd2lEPTB;MUSuO|c{PSEQvF2= NFv0ZotUSU6JRWK=
COLO-824 MmHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXPubVlrUUN3ME2xOE44QTl2IN88US=> M{HHeXNCVkeHUh?=
BC-3 M3fSO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUnvUHBrUUN3ME2xOU4{QThizszN M4KyVnNCVkeHUh?=
BOKU NWjVN|ZMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVWyc2k1UUN3ME2xOU46PjB6IN88US=> MlLpV2FPT0WU
GOTO M1;iZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3L2PGlEPTB;MU[uPVYyPyEQvF2= MWTTRW5ITVJ?
HCC2157 M2fCeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1nFb2lEPTB;MUeuOFc2PSEQvF2= MkTwV2FPT0WU
LS-1034 NYDJUIszT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlnhTWM2OD1zNz62PFE5KM7:TR?= NGHTRWNUSU6JRWK=
CAL-148 NYDTVmxyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1WzfmlEPTB;MUeuPVc6PiEQvF2= NITOZmlUSU6JRWK=
MOLT-4 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVL3SpBXUUN3ME2xPE45OjB6IN88US=> MnnJV2FPT0WU
Daudi M2jKNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDMZnZKSzVyPUG4MlkzOzFizszN M3fIfXNCVkeHUh?=
J-RT3-T3-5 MluwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUS1dnp6UUN3ME2xPU41ODZ4IN88US=> MnziV2FPT0WU
KMOE-2 NXuzdlJZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGHh[G9KSzVyPUG5MlY1QDJizszN NH\JW49USU6JRWK=
HL-60 M4nmWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYHJR|UxRTJyLkG5OlUh|ryP MlvtV2FPT0WU
P31-FUJ NH3BNoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlvmTWM2OD1{MD60O|U{KM7:TR?= Mmr0V2FPT0WU
IM-9 M{TJeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWTJR|UxRTJyLk[yNlQh|ryP MWLTRW5ITVJ?
HDLM-2 M3zwc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fZe2lEPTB;MkCuPFgzOSEQvF2= NEjVWmxUSU6JRWK=
NCI-H1304 NXv2dphtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4juU2lEPTB;MkGuNFMyOSEQvF2= NGHkdmtUSU6JRWK=
NCI-H345 NEn0N|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUX4NolIUUN3ME2yNU4xPjR|IN88US=> MWXTRW5ITVJ?
RPMI-6666 MlTZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1jJfmlEPTB;MkGuN|YxOiEQvF2= M1PpZXNCVkeHUh?=
GR-ST MkjmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV70XFBVUUN3ME2yNU41OTdizszN MWrTRW5ITVJ?
CHP-126 M3;3Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUTJR|UxRTJzLk[xPFEh|ryP NUezSXRbW0GQR1XS
EHEB M3vteWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIXOVG9KSzVyPUKxMlY4OzFizszN MnLkV2FPT0WU
CPC-N NH;NTGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWHyellNUUN3ME2yOE4xOjBzIN88US=> NXr2[FNqW0GQR1XS
NB1 NILLOplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTJ2Lk[5N|kh|ryP MnPWV2FPT0WU
LS-123 NXWxbXpTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1fhdWlEPTB;MkSuPVAyOiEQvF2= NXW1W|JsW0GQR1XS
ST486 MmjGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGHHdoFKSzVyPUK1MlEyOTNizszN MmPOV2FPT0WU
NCI-H1963 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{nmOGlEPTB;Mk[uNFYzOyEQvF2= MmD3V2FPT0WU
U-87-MG NXn1THhxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml3wTWM2OD1{Nj63OlQ1KM7:TR?= NFTLNHpUSU6JRWK=
COR-L279 M4TIdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2rFOmlEPTB;Mk[uO|kzOiEQvF2= MnvZV2FPT0WU
LU-165 NYixS4lPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYPBTYI6UUN3ME2yPE4xQDZzIN88US=> M2\xZnNCVkeHUh?=
COLO-800 NInTO5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXnJR|UxRTJ6LkK5OVYh|ryP MVjTRW5ITVJ?
ETK-1 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlLUTWM2OD1{OD6zOFQ3KM7:TR?= NVK2RlZ[W0GQR1XS
LNCaP-Clone-FGC NGXlTJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXXiSYJmUUN3ME2yPU46OjhzIN88US=> NFrmS5dUSU6JRWK=
SIG-M5 NX2wWmxpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3PYOGlEPTB;M{CuO|k2OiEQvF2= MVHTRW5ITVJ?
NB6 Ml;rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mlr6TWM2OD1|MD65OVA{KM7:TR?= MV3TRW5ITVJ?
NCI-H2107 NWrPTHFiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEPsS5NKSzVyPUOxMlI{OzhizszN MX7TRW5ITVJ?
SNU-C1 NVjRUJk2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1:5NmlEPTB;M{GuN|EzPiEQvF2= NHPEV4RUSU6JRWK=
JAR NE\zW|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1LkTGlEPTB;M{GuN|c6QSEQvF2= M4HqWnNCVkeHUh?=
L-363 NEPIUlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoXXTWM2OD1|Mj6yNVQ1KM7:TR?= M2O2TXNCVkeHUh?=
EW-24 Mn2zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVrHWXNIUUN3ME2zNk4{PDd2IN88US=> MXXTRW5ITVJ?
NB69 MlzpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXPJR|UxRTN|Lk[0OVQh|ryP Mn:zV2FPT0WU
EW-13 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVHJR|UxRTN|Lki5Olkh|ryP NYe0TFZpW0GQR1XS
Ramos-2G6-4C10 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1\C[GlEPTB;M{SuNlk6OyEQvF2= NGDE[YRUSU6JRWK=
TE-11 NVmyTGtCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYfJR|UxRTN2LkS4NlIh|ryP NFfrdFdUSU6JRWK=
L-428 NEn0SnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYX6TVRtUUN3ME2zOE44PTN4IN88US=> NWnQTYYyW0GQR1XS
KP-N-YN NVHifJRVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUDBcWZQUUN3ME2zOE46ODV5IN88US=> NVf2dmpJW0GQR1XS
CGTH-W-1 M2LtWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHPORY9KSzVyPUO2MlkxPDhizszN MmXoV2FPT0WU
K-562 NITOV4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnuzTWM2OD1|Nz6wPFY1KM7:TR?= MWrTRW5ITVJ?
NCI-H1299 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYTJR|UxRTN6LkG2NFMh|ryP MWPTRW5ITVJ?
RCC10RGB NF2yVYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1T5[GlEPTB;M{iuNlA5OyEQvF2= M3PxeHNCVkeHUh?=
NCI-SNU-16 M{Wyc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1fXWGlEPTB;M{iuOVY2OyEQvF2= NXLmb4Q2W0GQR1XS
LC-2-ad MoLDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2LJfWlEPTB;M{muOFM{PyEQvF2= NV\CVnBvW0GQR1XS
MHH-PREB-1 M{\hbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVm0V5c6UUN3ME2zPU44Ozh6IN88US=> NEjqTXpUSU6JRWK=
NCI-H64 M2rOZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTRyLkC5OFgh|ryP NX62SnM4W0GQR1XS
LB996-RCC M3vQbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU\ZZnBMUUN3ME20NE45PzF4IN88US=> NVXiRmp4W0GQR1XS
DEL NFHNSplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYPJR|UxRTRzLkS0NFUh|ryP M1r4[nNCVkeHUh?=
MLMA MmnDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{LyfGlEPTB;NEGuO|U6PSEQvF2= MkLIV2FPT0WU
SBC-1 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkfZTWM2OD12Mj6xPFA3KM7:TR?= MYDTRW5ITVJ?
MPP-89 NWfqW25tT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnzSTWM2OD12Mj61PFc2KM7:TR?= NH\kblJUSU6JRWK=
MV-4-11 NI\DPZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHWyb3hKSzVyPUSyMlkxPjdizszN MWTTRW5ITVJ?
EoL-1- NXL5ToF1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWXofldYUUN3ME20OE4yPTZ6IN88US=> MYnTRW5ITVJ?
CW-2 NVTvNWQ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIfmXHpKSzVyPUS0Mlg{PDJizszN NVXFUY1{W0GQR1XS
HT MoTLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MljCTWM2OD12NT63NFA4KM7:TR?= MXrTRW5ITVJ?
SW954 MlG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mne4TWM2OD12Nz60NVI5KM7:TR?= MmDrV2FPT0WU
A3-KAW NYjaVVNuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIX4TlBKSzVyPUS5MlgxPjFizszN MmTnV2FPT0WU
TC-YIK NHjqZ3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2Xi[GlEPTB;NUCuNFM3OyEQvF2= Mnn4V2FPT0WU
SW962 NFPZbZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mln3TWM2OD13ND64N|U4KM7:TR?= NH7ReGdUSU6JRWK=
KP-N-RT-BM-1 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV3x[VhiUUN3ME21Ok43PjN6IN88US=> M3mwW3NCVkeHUh?=
NCI-H1395 NYfFVG9XT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{fUVWlEPTB;NUiuPFE4OiEQvF2= MUjTRW5ITVJ?
RPMI-8402 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEi2OXVKSzVyPUW4Mlk2OjZizszN NELkZ5ZUSU6JRWK=
SCH MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHrIXGpKSzVyPU[wMlk3OzhizszN NUf3eFdqW0GQR1XS
NCI-H2196 MmKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGeyTmFKSzVyPU[xMlI{OSEQvF2= MmXnV2FPT0WU
LOXIMVI M{DVNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUXJR|UxRTZzLkiyOlYh|ryP MXXTRW5ITVJ?
TGBC24TKB MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWDzWIs3UUN3ME22Nk4yPDlzIN88US=> NHntV|ZUSU6JRWK=
SK-MEL-2 NGPqWZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NETIflBKSzVyPU[zMlk5QTJizszN MYnTRW5ITVJ?
U-698-M NVfnZmZGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVHveZNtUUN3ME22PE42Pjh5IN88US=> NXnIboxYW0GQR1XS
NCI-H1522 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NInoZo9KSzVyPU[5MlAxPDdizszN MnXaV2FPT0WU
UACC-812 MnrKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3W1cmlEPTB;NkmuOVIxQSEQvF2= MVPTRW5ITVJ?
MHH-CALL-2 NXjlVFFET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH3mTmNKSzVyPUewMlA3KM7:TR?= MlrVV2FPT0WU
NB5 NFrKXIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVjkWFZtUUN3ME23NE4{PDZ6IN88US=> NFzmWHdUSU6JRWK=
KARPAS-299 NITo[WZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M13TO2lEPTB;N{CuOFQ1PyEQvF2= Ml3JV2FPT0WU
NCI-H1694 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWDx[VZDUUN3ME23NU4xOzJizszN MmXsV2FPT0WU
NCI-H82 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUiwTm5WUUN3ME23NU46PTB5IN88US=> MkXSV2FPT0WU
SCC-15 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFribXBKSzVyPUeyMlM1KM7:TR?= NUfrSHFTW0GQR1XS
NCI-H1436 NYD1[4ZCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX\JR|UxRTd{Lke0OVYh|ryP M1TuZ3NCVkeHUh?=
ATN-1 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXvJR|UxRTd2LkWwOUDPxE1? M4jTXXNCVkeHUh?=
RPMI-8866 NGHpUJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH76enJKSzVyPUe0Mlc2ODlizszN M4W4d3NCVkeHUh?=
HCC1599 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUDJR|UxRTd2Lki3N|Ih|ryP NWjPdXo6W0GQR1XS
NCI-H1155 Mk[zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVzmbItOUUN3ME23OE46OzZ5IN88US=> M2iwcnNCVkeHUh?=
DOHH-2 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml73TWM2OD15ND65OVE1KM7:TR?= M1HRN3NCVkeHUh?=
SK-NEP-1 NV7ENmhWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MU\JR|UxRTd3LkC3OVQh|ryP MXLTRW5ITVJ?
HCC1187 NEe1ZnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVnJR|UxRTd5Lk[xNlIh|ryP MXvTRW5ITVJ?
NCI-H322M MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYW3cHBoUUN3ME23PE4{PzB7IN88US=> NIrZTm1USU6JRWK=
NCI-H526 NVfjUnFYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2HKcWlEPTB;N{iuOVg4PyEQvF2= MmrKV2FPT0WU
NCI-H2171 NU\1d|RiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1HPWWlEPTB;N{muOFE{PiEQvF2= Mli0V2FPT0WU
COLO-668 NYL0dpZRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1O4SmlEPTB;OEGuOVg5PCEQvF2= NVLUWpBHW0GQR1XS
RS4-11 NHPYeIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3v2[GlEPTB;OEKuNlUxPSEQvF2= NVOwcG5xW0GQR1XS
NCI-H716 NVnTSIY{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEfUdI1KSzVyPUiyMlkxPzVizszN MYfTRW5ITVJ?
LU-134-A NHrsWVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml21TWM2OD16Mz6xN|UyKM7:TR?= NUOzb2xRW0GQR1XS
RPMI-8226 M3:2Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWnJR|UxRTh2LkKxNFch|ryP MmPyV2FPT0WU
KY821 M1nFPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2XMS2lEPTB;OUGuOlU2OSEQvF2= NH[2VJVUSU6JRWK=
ECC4 M2nFWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF3r[lZKSzVyPUmzMlgzPjlizszN M1vuXXNCVkeHUh?=
EW-3 MkToS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGi3XYdKSzVyPUm0MlkxQDFizszN MXzTRW5ITVJ?
NB7 NEHZclFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{PROGlEPTB;OUWuO|c5PiEQvF2= Ml;CV2FPT0WU
NCI-H720 M3jx[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXK0O4JCUUN3ME25PE41ODZzIN88US=> MWDTRW5ITVJ?
NCI-H446 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTl7Lke1PFgh|ryP NED3Vm9USU6JRWK=
NCI-H889 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlLDTWM2OD1zMESuNlQzKM7:TR?= NV;RdnNVW0GQR1XS
EW-22 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4n3XGlEPTB;MUC2MlE6KM7:TR?= NH7mVo9USU6JRWK=
BV-173 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4LRWGlEPTB;MUC4MlczQCEQvF2= M{i4UXNCVkeHUh?=
WSU-NHL NVfpWoN5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MojMTWM2OD1zMEmuOlcyKM7:TR?= MUXTRW5ITVJ?
MN-60 NF[3T3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEPy[mRKSzVyPUGwPU43QSEQvF2= NHj3c|JUSU6JRWK=
DG-75 NFPVTldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGPZXGZKSzVyPUGxN{4{PTJizszN NVP5O2RxW0GQR1XS
DMS-79 NXnyOlY{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mni0TWM2OD1zMUeuN|gzKM7:TR?= MVjTRW5ITVJ?
SK-MEL-1 NGjLeHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3XRU2lEPTB;MUG4MlAxQSEQvF2= M3q0fnNCVkeHUh?=
DMS-153 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NY\M[IF1UUN3ME2xNlEvPzR3IN88US=> NFS1ToxUSU6JRWK=
NCI-H510A MmWwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoLMTWM2OD1zMkeuN|Ih|ryP MmPBV2FPT0WU
BE-13 NFTRcVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF3CbVJKSzVyPUGzOE4xPDRizszN Ml7BV2FPT0WU
KP-N-YS NFHNZnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWPJR|UxRTF|OT63N|Yh|ryP M{D3fXNCVkeHUh?=
SUP-T1 M{\xXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWTJR|UxRTF2Mz63NFgh|ryP NYW3Vpd{W0GQR1XS
EW-12 NF7VW4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEDQZ|JKSzVyPUG0OE43QTlizszN NInPfWJUSU6JRWK=
NB14 NHLzco9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFP6TWxKSzVyPUG0O{4xQDJizszN NGG2VoFUSU6JRWK=
MDA-MB-134-VI NWPLNnA3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGfmb4VKSzVyPUG0PE4zPjhizszN MmfPV2FPT0WU
NCI-H1770 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2H5cmlEPTB;MUW2MlI4QSEQvF2= MVXTRW5ITVJ?
TUR MlzQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn\ITWM2OD1zNkeuPFch|ryP NYPmbY1wW0GQR1XS
NCI-H1417 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVO0NpB2UUN3ME2xPFAvOzNzIN88US=> MmnmV2FPT0WU
IMR-5 NXHuXId{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkLITWM2OD1zOEGuOVcyKM7:TR?= M4DnWnNCVkeHUh?=
NCI-H226 Mn:wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmjuTWM2OD1zOEiuPFY3KM7:TR?= MlPJV2FPT0WU
NCI-H187 M3fmPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYfJR|UxRTF7MD6wOlQh|ryP M1XtfnNCVkeHUh?=
SF539 NFLMXlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NG\zS|hKSzVyPUG5Nk44OjhizszN NEKwUHNUSU6JRWK=
TALL-1 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFS3PXRKSzVyPUG5PE4{ODRizszN MnPLV2FPT0WU
TE-441-T NFXpXJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUHJR|UxRTF7OT63N|kh|ryP MX3TRW5ITVJ?
REH NFvuNFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVvqepl[UUN3ME2yN|YvPjJ4IN88US=> M{XnZnNCVkeHUh?=
MS-1 MkXxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2fldWlEPTB;MkO5MlEzOSEQvF2= M{jwbnNCVkeHUh?=
THP-1 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlzaTWM2OD1{NkSuO|M5KM7:TR?= M4LCenNCVkeHUh?=
NCI-H1838 M{OyTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH\ScXNKSzVyPUK3NU41PTZizszN M3jNSXNCVkeHUh?=
P30-OHK NGfpSIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1:3UGlEPTB;MkizMlg1PyEQvF2= NGj0e3NUSU6JRWK=
C8166 MofvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnmwTWM2OD1|NEWuN|M5KM7:TR?= Mm[zV2FPT0WU

多くの細胞株試験データを見る場合、クリックしてください

体内試験 Administration of MG-132 effectively rescues the expression levels and plasma membrane localization of dystrophin, β-dystroglycan, α-bdystroglycan, and α-sarcoglycan in skeletal muscle fibers from mdx mice, reduces muscle membrane damage, and ameliorates the histopathological signs of muscular dystrophy. [7] MG-132 treatment significantly reduces immobilization-induced skeletal muscle atrophy in mice, by downregulating the muscle-specific ubiquitin ligases atrogin-1/MAFbx and MuRF-1 mRNA. [8]

お薦めの試験操作(参考用のみ)

キナーゼ試験:

[1]

+ 展開

Measurement of inhibitory activities of MG-132 against 20S proteasome:

The reaction mixture for the 20S proteasome inhibitory assay contains 0.1 M Tris-acetate, pH 7.0, 20S proteasome, MG-132, and 25 μM substrate dissolved in dimethyl sulfoxide in a final volume of 1 mL. After incuba tion at 37 °C for 15 minutes, the reaction is stopped by the addition of 0.1 mL of 10% SDS and 0.9 mL of 0.1M Tris acetate, pH 9.0. The fluorescence of the reaction products is measured. To determine the IC50 against 20S proteasome, various concentrations of MG-132 are included in the assay mixture.
細胞試験:

[3]

+ 展開
  • 細胞株: KIM-2, HC11, and ES
  • 濃度: Dissolved in DMSO, final concentrations ~25 μM
  • 反応時間: 24 and 48 hours
  • 実験の流れ:

    Cells are exposed to various concentrations of MG-132 for 24, and 48 hours. Supernatant and monolayer cells are harvested by centrifugation and fixed in 70% ethanol in PBS for staining with acridine orange. Equal volumes of cells and acridine orange (5 mg/mL in PBS) are mixed on a microscope slide and examined by fluorescence microscopy. For annexin V analysis, cells are harvested by centrifugation and stained with annexin V and propidium iodide. For cell cycle analysis, cells are rehydrated in PBS at room temperature for 10 minutes, followed by staining with propidium iodide (5 mg/mL). All samples are analyzed using a Coulter Epics XL flow cytometer.


    (参考用のみ)
動物試験:

[7]

+ 展開
  • 動物モデル: Male mdx (C57BL/10ScSn DMD mdx) mice
  • 製剤: Dissolved in DMSO, and diluted in PBS
  • 投薬量: ~10 μg/kg/day
  • 投与方法: Injection
    (参考用のみ)

溶解度 (25°C)

体外 DMSO 90 mg/mL (189.22 mM)
Ethanol 25 mg/mL (52.56 mM)
Water Insoluble
体内 左から(NMPから)右の順に溶剤を製品に加えます:
4% DMSO+30% PEG 300+20% propylene glycol+ddH2O
混合させたのち直ちに使用することを推奨します。
2mg/mL

* 溶解度測定はSelleck技術部門によって行われており、その他文献に示されている溶解度と差異がある可能性がありますが、同一ロットの生産工程で起きる正常な現象ですからご安心ください。

化学情報

分子量 475.62
化学式

C26H41N3O5

CAS No. 133407-82-6
保管
in solvent
別名 N/A

便利ツール

モル濃度計算器

モル濃度計算器

解決のために必要とされるマス、ボリュームまたは濃度を計算してください。

マス (g) = 濃度 (mol/L) x ボリューム (L) x 分子量 (g/mol)

モル濃度計算器方程式

  • マス
    濃度
    ボリューム
    分子量

*貯蔵液を準備するとき、常に、オンであるとわかる製品のバッチに特有の分子量を使って、を通してラベルとMSDS/COA(製品ページで利用可能な)。

希釈計算器

希釈計算器

貯蔵液を準備することを要求される希釈剤を計算してください. セレック希釈計算器は、以下の方程式に基づきます:

開始濃度 x 開始体積 = 最終濃度 x 最終体積

希釈の計算式

この方程式は、一般に略語を使われます:C1V1 = C2V2 ( 輸入 輸出 )

  • C1
    V1
    C2
    V2

常に貯蔵液を準備するとき、小びんラベルとMSDS/COA(オンラインで利用できる)で見つかる製品のバッチに特有の分子量を使ってください。

連続希釈計算器方程式

  • 連続希釈剤

  • 計算結果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量計算器

分子量计算器

そのモル質量と元素組成を計算するために、合成物の化学式を入力してください:

総分子量:g/mol

チップス: 化学式は大文字と小文字の区別ができます。C10H16N2O2 c10h16n2o2

モル濃度計算器

マス 濃度 ボリューム 分子量

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

  • * 必須

よくある質問(FAQ)

  • 質問1:

    I want to know whether it contains EDTA or other chelating agent in this product(S2619)?

  • 回答:

    Our S2619 MG-132 doesn't contain EDTA or other chelating agent.

Proteasomeシグナル伝達経路

Proteasome Inhibitors with Unique Features

相関Proteasome製品

Tags: MG-132を買う | MG-132 ic50 | MG-132供給者 | MG-132を購入する | MG-132費用 | MG-132生産者 | オーダーMG-132 | MG-132化学構造 | MG-132分子量 | MG-132代理店
×
細胞株 試験類型 濃度 培養時間 溶剤類型 活性叙述 PMID